Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots... Show more
PEN is expected to report earnings to rise 12.37% to $1.09 per share on February 24
Q4'25
Est.
$1.09
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.16
Q4'24
Beat
by $0.07
The last earnings report on November 05 showed earnings per share of 97 cents, beating the estimate of 92 cents. With 132.41K shares outstanding, the current market capitalization sits at 10.98B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PEN showed earnings on November 05, 2025. You can read more about the earnings report here.